July 11, 2017 — Volpara Solutions Inc. will showcase its new Volpara Enterprise DDP software at the Association for Medical Imaging Management (AHRA)'s 45th Annual Meeting and Exposition, July 9-12, in Anaheim, Calif. The VolparaEnterprise Clinical Applications software package offers access to VolparaDensity, VolparaDose and VolparaPressure, in a software-as-a-service (SaaS) subscription model for the first time. Volpara Solutions will showcase its entire suite of quantitative breast imaging tools, which allow for personalized measurements of volumetric breast density, patient dose, breast compression and other factors designed to help maintain accuracy and consistent quality in breast screening.
VolparaEnterprise Clinical Applications provide quick, automated assessment of every mammography and tomosynthesis exam and produces a Volpara Scorecard for every patient with the following data:
- VolparaDensity helps radiologists assess breast density more objectively and helps them better consider who might benefit from additional screening. The volumetric Volpara Density Grades have been shown to correlate strongly to the sensitivity of mammography and have demonstrated a strong association with the risk of developing breast cancer;
- VolparaDose helps understand the X-ray dose delivered to the patient, based on her specific breast density. Unlike manufacturer dose, which is based on phantom measurements, VolparaDose is computed based on the patient's breast composition and provides a personalized dose measure because no two women are alike; and
- VolparaPressure helps evaluate the effectiveness of the mammogram and better understand the patient experience. The lack of consistent guidelines regarding mammographic compression has led to wide variation in its technical execution, as well as varying levels of discomfort or pain. VolparaPressure helps monitor and optimize pressure during mammography exams, which is important to decrease the discomfort experienced by women and to optimize screening outcomes.
VolparaEnterprise software, a Microsoft Azure-based solution, delivers key performance indicators (KPIs) for hundreds of performance and quality metrics, including patient positioning, compression and equipment utilization. The software provides continuous quality assurance and performance monitoring through dynamic, interactive dashboards. Updated with every mammography or tomosynthesis (3-D mammography) exam, ConstantQuality metrics may help facilities comply with the U.S. Food and Drug Administration’s (FDA's) new Enhancing Quality Using the Inspection Program (EQUIP).
Designed to support large or small enterprises, VolparaEnterprise software enables breast centers to perform rapid quality control checks that help optimize the productivity and efficiency of imaging resources. This in turn helps decrease costs through the reduction of retakes, increase employee effectiveness, and enhance the patient experience.
For more information: www.volparasolutions.com
March 06, 2026 
